Pharma News

The European Commission has granted marketing authorization for Idorsia’s Quviviq (daridorexant) for the treatment of adult patients with chronic insomnia disorder. ...

Teva Pharmaceuticals and Lupin have settled their patent dispute over Lupin’s generic version of Teva’s Huntington’s disease drug, Austedo (deutetrabenazine). ...

AbbVie is off to a strong start for 2022, driven by success from Skyrizi and Rinvoq, as well as the company’s neuroscience platform that includes its depression treatments and its three-pronged a...

The U.S. Food and Drug Administration is quickly catching up after COVID-19 disrupted typical review timelines and planned inspections and it's bad news for three companies. 

Pfizer’s oral COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir) failed to show meaningful improvements in people who took it after exposure to COVID-19.

It has taken French rare disease specialist Orphalan 11 years to earn its first approval in the U.S. 

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced ...

Tirzepatide (5 mg, 10 mg, 15 mg) achieved superior weight loss compared to placebo at 72 weeks of treatment in topline results from Eli Lilly and Company's (NYSE: LLY) SURMOUNT-1 clinical trial, w...

AstraZeneca topped off a very busy week with its first-quarter financial report, citing a total of $11.390 billion in revenue, a whopping increase of 60%.  ...

The FDA and the European Commission have granted AviadoBio Orphan Drug designations for its investigational gene therapy, AVB-101, for the treatment of patients with frontotemporal dementia (FTD). ...

The FDA has approved Epsolay cream for the treatment of inflammatory lesions of rosacea, Sol-Gel Technologies announced in a press release.

The U.S. Food and Drug Administration (FDA) approved VIVJOA™ (oteseconazole capsules), an azole antifungal indicated to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in female...